David Drutz is Director at Altimmune, Inc. (ALT). They have made 10 open-market trades across 2 companies since 2012, most recently 2024-08-19.
CIK 0001428764
9 open-market purchases totalling $161K since 2012, against 1 sale. Across 5 scored buys the stock is up 69.1% at ninety days, and 63.9 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 80% | 40% |
| Avg Move | +12.7% | +34.9% | +69.1% |
| Alpha | +10.3% | +33.3% | +63.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALT | SELL | 2024-08-19 | 2024-08-20 | $6.90 | $221K | -5.6% | +6.6% | +0.7% |
| ALT | BUY | 2023-08-15 | 2023-08-15 | $2.88 | $864 | -14.3% | -0.4% | -12.9% |
| ALT | BUY | 2023-03-23 | 2023-03-27 | $4.27 | $38K | -17.1% | +7.9% | -28.7% |
| ALT | BUY | 2022-06-15 | 2022-06-16 | $8.00 | $8K | +56.1% | +41.5% | +97.2% |
| ALT | BUY | 2022-05-24 | 2022-05-25 | $4.50 | $5K | +25.3% | +120.8% | +295.5% |
| ALT | BUY | 2017-08-22 | 2017-08-24 | $2.21 | $22K | +13.6% | +4.5% | -5.5% |
| DARA | BUY | 2013-05-17 | 2013-05-20 | $0.70 | $18K | N/A | N/A | N/A |
| DARA | BUY | 2012-09-17 | 2012-09-17 | $1.06 | $27K | N/A | N/A | N/A |
| DARA | BUY | 2012-06-08 | 2012-06-11 | $0.77 | $19K | N/A | N/A | N/A |
| DARA | BUY | 2012-05-29 | 2012-05-30 | $0.90 | $23K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.